ASP7962

· Astellas Pharma Europe B.V.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ASP7962, covering 2014-07-11 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Analgesic Efficacy of ASP7962 in Patients With Pain Due to Osteoarthritis of the Knee [Phase 2]

See pricing